Wolverine Trading
TEVA icon

Wolverine Trading’s Teva Pharmaceuticals TEVA Stock Holding History

Wolverine Trading’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$4.15M Sell
216,400
-65,700
-23% -$1.15M ﹤0.01% 1535
2025
Q2 		$4.73M Sell
282,100
-80,500
-22% -$1.3M ﹤0.01% 1092
2025
Q1 		$5.47M Sell
362,600
-223,900
-38% -$4M 0.01% 943
2024
Q4 		$13.1M Buy
586,500
+268,700
+85% +$4.89M 0.01% 655
2024
Q3 		$5.55M Sell
317,800
-32,400
-9% -$567K 0.01% 974
2024
Q2 		$5.69M Sell
350,200
-25,200
-7% -$388K 0.01% 908
2024
Q1 		$5.3M Buy
375,400
+169,300
+82% +$2.13M 0.01% 983
2023
Q4 		$2.15M Sell
206,100
-62,500
-23% -$584K ﹤0.01% 1666
2023
Q3 		$2.74M Buy
268,600
+58,500
+28% +$545K ﹤0.01% 1361
2023
Q2 		$1.59M Buy
210,100
+29,600
+16% +$240K ﹤0.01% 1634
2023
Q1 		$1.59M Sell
180,500
-122,200
-40% -$1.21M ﹤0.01% 1532
2022
Q4 		$2.76M Buy
302,700
+57,900
+24% +$505K ﹤0.01% 1209
2022
Q3 		$1.91M Buy
244,800
+40,000
+20% +$354K ﹤0.01% 1447
2022
Q2 		$1.63M Buy
204,800
+78,700
+62% +$686K ﹤0.01% 1538
2022
Q1 		$1.18M Sell
126,100
-134,300
-52% -$1.12M ﹤0.01% 2278
2021
Q4 		$2.06M Sell
260,400
-118,600
-31% -$1.07M ﹤0.01% 1867
2021
Q3 		$3.78M Buy
379,000
+165,300
+77% +$1.55M ﹤0.01% 1533
2021
Q2 		$2.14M Buy
213,700
+31,800
+17% +$337K ﹤0.01% 1917
2021
Q1 		$2.06M Sell
181,900
-292,600
-62% -$3.36M ﹤0.01% 1902
2020
Q4 		$4.55M Buy
474,500
+234,300
+98% +$2.24M 0.01% 1124
2020
Q3 		$2.13M Sell
240,200
-57,200
-19% -$605K 0.01% 1431
2020
Q2 		$3.62M Sell
297,400
-150,700
-34% -$1.7M 0.01% 1006
2020
Q1 		$3.81M Buy
448,100
+166,800
+59% +$1.71M 0.01% 920
2019
Q4 		$2.73M Sell
281,300
-14,600
-5% -$130K 0.01% 1580
2019
Q3 		$2.05M Sell
295,900
-10,300
-3% -$78.9K 0.01% 1415
2019
Q2 		$2.83M Buy
306,200
+125,600
+70% +$1.51M 0.01% 1279
2019
Q1 		$2.83M Sell
180,600
-203,000
-53% -$3.58M 0.01% 1256
2018
Q4 		$6.02M Buy
383,600
+58,500
+18% +$1.2M 0.02% 699
2018
Q3 		$7M Buy
325,100
+112,900
+53% +$2.62M 0.02% 757
2018
Q2 		$3.63M Hold
212,200
– – 0.01% 1124
2018
Q1 		$3.63M Buy
+212,200
New +$4.14M 0.01% 1124
2017
Q4 		– Sell
-278,900
Closed -$4.91M – 5464
2017
Q3 		$4.91M Buy
278,900
+11,200
+4% +$252K 0.02% 774
2017
Q2 		$8.79M Buy
267,700
+76,700
+40% +$2.37M 0.04% 418
2017
Q1 		$6.25M Buy
191,000
+58,200
+44% +$1.99M 0.03% 543
2016
Q4 		$4.81M Buy
132,800
+34,600
+35% +$1.38M 0.02% 755
2016
Q3 		$4.55M Buy
98,200
+17,100
+21% +$892K 0.02% 788
2016
Q2 		$4.08M Buy
+81,100
New +$4.32M 0.02% 706

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Wolverine Trading's TEVA Position: Q3 2025 in Review

Wolverine Trading increased its Teva Pharmaceuticals (TEVA) stake by 88% in Q3 2025, buying an estimated $1.06M and bringing the position to 128,085 shares worth $2.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2000.

Wolverine Trading first reported a position in TEVA in Q2 2016 and has held it in 36 quarters since. The position peaked at $5.27M in Q4 2016. 550 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • Wolverine Trading held 128,085 shares of Teva Pharmaceuticals worth $2.46M as of Q3 2025.
  • Wolverine Trading bought 60,109 Teva Pharmaceuticals shares in Q3 2025, an estimated $1.06M.
  • Teva Pharmaceuticals made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2000 holding.
  • Wolverine Trading first reported a position in Teva Pharmaceuticals in Q2 2016 and has held it in 36 quarters since.
  • Wolverine Trading's Teva Pharmaceuticals position peaked at $5.27M in Q4 2016.
  • 550 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.